Logo image of LCID

LUCID GROUP INC (LCID) Stock Fundamental Analysis

USA - NASDAQ:LCID - US5494981039 - Common Stock

19.8 USD
+0.53 (+2.72%)
Last: 9/15/2025, 4:07:17 PM
19.7801 USD
-0.02 (-0.1%)
After Hours: 9/15/2025, 4:07:17 PM
Fundamental Rating

3

Overall LCID gets a fundamental rating of 3 out of 10. We evaluated LCID against 37 industry peers in the Automobiles industry. While LCID seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, LCID is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LCID has reported negative net income.
In the past year LCID has reported a negative cash flow from operations.
LCID had negative earnings in each of the past 5 years.
In the past 5 years LCID always reported negative operating cash flow.
LCID Yearly Net Income VS EBIT VS OCF VS FCFLCID Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -1B -2B -3B -4B

1.2 Ratios

With a Return On Assets value of -34.47%, LCID is not doing good in the industry: 62.16% of the companies in the same industry are doing better.
LCID has a Return On Equity (-71.55%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -34.47%
ROE -71.55%
ROIC N/A
ROA(3y)-32.48%
ROA(5y)-41.59%
ROE(3y)-58.77%
ROE(5y)-71.55%
ROIC(3y)N/A
ROIC(5y)N/A
LCID Yearly ROA, ROE, ROICLCID Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LCID so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LCID Yearly Profit, Operating, Gross MarginsLCID Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

5

2. Health

2.1 Basic Checks

LCID does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LCID has been increased compared to 1 year ago.
The number of shares outstanding for LCID has been increased compared to 5 years ago.
The debt/assets ratio for LCID has been reduced compared to a year ago.
LCID Yearly Shares OutstandingLCID Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1B 2B 3B
LCID Yearly Total Debt VS Total AssetsLCID Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

LCID has an Altman-Z score of -2.09. This is a bad value and indicates that LCID is not financially healthy and even has some risk of bankruptcy.
LCID has a Altman-Z score (-2.09) which is comparable to the rest of the industry.
LCID has a Debt/Equity ratio of 0.57. This is a neutral value indicating LCID is somewhat dependend on debt financing.
LCID has a Debt to Equity ratio of 0.57. This is in the better half of the industry: LCID outperforms 64.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z -2.09
ROIC/WACCN/A
WACC7.79%
LCID Yearly LT Debt VS Equity VS FCFLCID Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

A Current Ratio of 2.58 indicates that LCID has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.58, LCID belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
A Quick Ratio of 2.11 indicates that LCID has no problem at all paying its short term obligations.
LCID's Quick ratio of 2.11 is amongst the best of the industry. LCID outperforms 94.59% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.11
LCID Yearly Current Assets VS Current LiabilitesLCID Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

6

3. Growth

3.1 Past

LCID shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -146.72%.
Looking at the last year, LCID shows a very strong growth in Revenue. The Revenue has grown by 39.01%.
Measured over the past years, LCID shows a very strong growth in Revenue. The Revenue has been growing by 181.26% on average per year.
EPS 1Y (TTM)-146.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.24%
Revenue 1Y (TTM)39.01%
Revenue growth 3Y210.02%
Revenue growth 5Y181.26%
Sales Q2Q%29.34%

3.2 Future

The Earnings Per Share is expected to grow by 14.58% on average over the next years. This is quite good.
Based on estimates for the next years, LCID will show a very strong growth in Revenue. The Revenue will grow by 65.15% on average per year.
EPS Next Y88.91%
EPS Next 2Y38.82%
EPS Next 3Y25.06%
EPS Next 5Y14.58%
Revenue Next Year67.01%
Revenue Next 2Y79.74%
Revenue Next 3Y86.49%
Revenue Next 5Y65.15%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LCID Yearly Revenue VS EstimatesLCID Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
LCID Yearly EPS VS EstimatesLCID Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LCID reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LCID is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LCID Price Earnings VS Forward Price EarningsLCID Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LCID Per share dataLCID EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

LCID's earnings are expected to grow with 25.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.82%
EPS Next 3Y25.06%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LCID!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUCID GROUP INC

NASDAQ:LCID (9/15/2025, 4:07:17 PM)

After market: 19.7801 -0.02 (-0.1%)

19.8

+0.53 (+2.72%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners73.23%
Inst Owner Change1.71%
Ins Owners0.32%
Ins Owner Change6.02%
Market Cap6.08B
Analysts54.29
Price Target25.34 (27.98%)
Short Float %N/A
Short Ratio2.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.41%
Min EPS beat(2)-11.38%
Max EPS beat(2)14.21%
EPS beat(4)3
Avg EPS beat(4)6.85%
Min EPS beat(4)-11.38%
Max EPS beat(4)15.08%
EPS beat(8)5
Avg EPS beat(8)2.1%
EPS beat(12)7
Avg EPS beat(12)1.61%
EPS beat(16)10
Avg EPS beat(16)4.35%
Revenue beat(2)0
Avg Revenue beat(2)-8.27%
Min Revenue beat(2)-9.12%
Max Revenue beat(2)-7.41%
Revenue beat(4)1
Avg Revenue beat(4)-2.54%
Min Revenue beat(4)-9.12%
Max Revenue beat(4)7.31%
Revenue beat(8)3
Avg Revenue beat(8)-5.09%
Revenue beat(12)3
Avg Revenue beat(12)-9.27%
Revenue beat(16)4
Avg Revenue beat(16)-15.7%
PT rev (1m)841.68%
PT rev (3m)882.96%
EPS NQ rev (1m)-897.28%
EPS NQ rev (3m)-996.18%
EPS NY rev (1m)-5.29%
EPS NY rev (3m)-4.15%
Revenue NQ rev (1m)-5.12%
Revenue NQ rev (3m)-4.07%
Revenue NY rev (1m)-3.45%
Revenue NY rev (3m)-5.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.55
P/FCF N/A
P/OCF N/A
P/B 1.42
P/tB 1.42
EV/EBITDA N/A
EPS(TTM)-9.4
EYN/A
EPS(NY)-0.6
Fwd EYN/A
FCF(TTM)-9.93
FCFYN/A
OCF(TTM)-7.34
OCFYN/A
SpS3.02
BVpS13.9
TBVpS13.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.47%
ROE -71.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-32.48%
ROA(5y)-41.59%
ROE(3y)-58.77%
ROE(5y)-71.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 215.3%
Cap/Sales 85.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.11
Altman-Z -2.09
F-Score4
WACC7.79%
ROIC/WACCN/A
Cap/Depr(3y)421.76%
Cap/Depr(5y)1286.62%
Cap/Sales(3y)146.37%
Cap/Sales(5y)2710.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.24%
EPS Next Y88.91%
EPS Next 2Y38.82%
EPS Next 3Y25.06%
EPS Next 5Y14.58%
Revenue 1Y (TTM)39.01%
Revenue growth 3Y210.02%
Revenue growth 5Y181.26%
Sales Q2Q%29.34%
Revenue Next Year67.01%
Revenue Next 2Y79.74%
Revenue Next 3Y86.49%
Revenue Next 5Y65.15%
EBIT growth 1Y-0.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year15.75%
EBIT Next 3Y16.43%
EBIT Next 5Y14.56%
FCF growth 1Y18.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y17.09%
OCF growth 3YN/A
OCF growth 5YN/A